Trong cc nhm thuc gim cn hin nay, thuc ng vn th th GLP-1 ni bt vi li ch gim cn ng k, trong s , tirzepatide hin ang l i din mi nht va c FDA ph duyt
A 2025 review published in PMC ( Alopecia and Semaglutide: Connecting the Dots for Patient Safety , Branyiczky et al., International Journal of Dermatology ) specifically highlights micronutrient depletion particularly iron, zinc, vitamin D, and biotin as a primary pathway, noting these are well-recognised triggers for telogen effluvium. Hormonal disruption
Supplementing with L-carnitine supports regenerative processes in the eye tissues, which is especially important for older individuals or those exposed to eye strain
The market is heading for a shake-up, however, as Novo Nordisk is heading for the loss of patent protection for its GLP-1 agonist semaglutide in China before the end of this month, which could be followed by the entry of lower-cost generic alternatives